| Literature DB >> 5115829 |
M P Cole, C T Jones, I D Todd.
Abstract
An introductory clinical trial of the anti-oestrogenic agent IC146474 in late or recurrent carcinoma of the breast is described.Forty-six patients have been treated, of whom 10 have shown a good response. This is of the same order as that seen with oestrogens and androgens.The particular advantage of this drug is the low incidence of troublesome side effects.Entities:
Mesh：
Substances：
Year: 1971 PMID： 5115829 PMCID： PMC2008453 DOI： 10.1038/bjc.1971.33
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640